HESI RN ADVANCED
PHARMACOLOGY EXAM
NEWEST VERSION | 2026/2027
Actual Exam Complete | Already Graded A+
160 Questions | 13 Content Sections
Aligned with NCBSN Pharmacology Competencies
Format Multiple Choice (A-D) | Verified Answers
Total Questions 160
Sections 13 (Pharmacokinetics through Case Studies)
Cognitive Levels 25% Recall | 55% Application | 20% Analysis
Focus Drug Therapy Integration & Clinical Application
160 Questions | 13 Sections | Verified Answers with Detailed Rationales
,HESI RN Advanced Pharmacology Exam 2026/2027 Page 2
Section 1: Pharmacokinetics and Pharmacodynamics
Q1: A nurse is administering a medication that undergoes extensive
first-pass metabolism. Which of the following best describes the effect of
first-pass metabolism on the drug?
A. Increased bioavailability of the active drug
B. Decreased bioavailability due to hepatic inactivation before reaching
systemic circulation [CORRECT]
C. Enhanced renal excretion of the drug
D. Prolonged half-life of the drug
Correct Answer: B
Rationale:
First-pass metabolism refers to the hepatic inactivation of a drug before it reaches systemic
circulation, significantly reducing its bioavailability. Drugs undergoing extensive first-pass
effect (e.g., morphine, propranolol, nitroglycerin) often require alternative routes such as
sublingual or IV administration to bypass this effect. Options A and D are incorrect because
first-pass metabolism reduces, not increases, bioavailability and does not directly
determine half-life. Option C is incorrect because first-pass metabolism involves hepatic
metabolism, not renal excretion.
Q2: A patient with severe liver cirrhosis is prescribed a highly protein-bound
drug (99% bound to albumin). The nurse should understand that which of
the following is the most likely consequence in this patient?
A. Decreased free drug concentration due to increased albumin synthesis
B. Increased free drug concentration leading to an enhanced
pharmacological effect and risk of toxicity [CORRECT]
C. No change in drug effect because protein binding is unaffected by liver disease
D. Increased rate of renal excretion due to decreased protein binding
Correct Answer: B
Rationale:
Severe liver cirrhosis impairs albumin synthesis, leading to hypoalbuminemia and fewer
available protein-binding sites. This increases the fraction of unbound (free) drug, which is
the pharmacologically active form, thereby enhancing drug effect and increasing the risk of
toxicity. Option A is incorrect because the liver synthesizes albumin and cirrhosis
decreases, not increases, albumin production. Option C is incorrect because protein
binding is directly affected by decreased albumin levels. Option D describes a potential
downstream effect but is not the most direct or immediate consequence of
hypoalbuminemia.
Q3: A nurse is reviewing medications for a patient with a severe systemic
infection. Which characteristic of a drug's volume of distribution (Vd) best
explains why certain antibiotics (e.g., vancomycin) have limited penetration
into cerebrospinal fluid?
HESI RN ADVANCED PHARMACOLOGY EXAM 2026/2027
,HESI RN Advanced Pharmacology Exam 2026/2027 Page 3
A. Low Vd indicates the drug is confined to the bloodstream and interstitial
fluid [CORRECT]
B. High Vd indicates the drug readily crosses the blood-brain barrier
C. Low Vd increases the drug's half-life in cerebrospinal fluid
D. High Vd decreases the drug's protein-binding capacity
Correct Answer: A
Rationale:
A low volume of distribution means the drug is primarily confined to the intravascular
space and interstitial fluid, with limited distribution into tissues including the central
nervous system. Vancomycin has a relatively low Vd and does not readily cross the
blood-brain barrier, which is why it has limited CSF penetration unless the meninges are
inflamed. Option B is incorrect because a high Vd indicates wide tissue distribution but
does not guarantee BBB penetration. Options C and D are incorrect because Vd does not
directly determine half-life in CSF or protein-binding capacity.
Q4: A nurse is caring for a client who is taking warfarin (Coumadin) and is
prescribed phenobarbital for seizures. Which of the following explains the
likely interaction between these two medications?
A. Phenobarbital inhibits CYP2C9, increasing warfarin levels and bleeding risk
B. Phenobarbital induces CYP450 enzymes, decreasing warfarin's
anticoagulant effect [CORRECT]
C. Phenobarbital competes with warfarin for plasma protein-binding sites,
increasing free warfarin
D. Phenobarbital decreases warfarin absorption by increasing gastric pH
Correct Answer: B
Rationale:
Phenobarbital is a potent CYP450 enzyme inducer that increases the hepatic metabolism of
warfarin, a CYP2C9 substrate, leading to decreased warfarin levels and a reduced
anticoagulant effect. This is a pharmacokinetic interaction involving enzyme induction, and
patients may require higher warfarin doses or closer INR monitoring. Option A is incorrect
because phenobarbital induces, not inhibits, CYP enzymes. Option C is incorrect because
the primary interaction mechanism is enzyme induction, not protein-binding displacement.
Option D is incorrect because phenobarbital does not significantly alter gastric pH or
warfarin absorption.
Q5: A patient receives an IV bolus of a medication with a half-life of 4 hours.
Approximately how many hours will it take for the drug to reach
approximately 94% of steady-state concentration with a continuous infusion?
A. 8 hours
B. 12 hours
C. 16 hours [CORRECT]
D. 24 hours
Correct Answer: C
Rationale:
HESI RN ADVANCED PHARMACOLOGY EXAM 2026/2027
, HESI RN Advanced Pharmacology Exam 2026/2027 Page 4
It takes approximately 4 to 5 half-lives for a drug to reach steady-state concentration during
continuous infusion. At 4 half-lives (4 × 4 = 16 hours), approximately 94% of steady-state is
achieved. At 5 half-lives (20 hours), approximately 97% is achieved. Eight hours (2
half-lives) reaches only about 75%, and 12 hours (3 half-lives) reaches about 87.5%, making
16 hours the best answer for "approximately 94%." Option D (24 hours) exceeds the time
needed for 94% steady-state.
Q6: A nurse is administering theophylline intravenously to a patient with an
acute asthma exacerbation. The nurse should recognize that theophylline
follows which type of kinetics and what is the clinical implication?
A. First-order kinetics; a constant fraction of the drug is eliminated per unit time
B. Zero-order kinetics; a constant amount of the drug is eliminated per unit
time and small dose increases can cause disproportionate toxicity
[CORRECT]
C. First-order kinetics; a constant amount of the drug is eliminated per unit time
D. Zero-order kinetics; the drug is primarily eliminated by renal excretion
Correct Answer: B
Rationale:
Theophylline follows zero-order (saturable) kinetics at therapeutic or near-toxic
concentrations, meaning a constant amount of drug is eliminated per unit time rather than
a constant fraction. In zero-order kinetics, small increases in dose or concentration can lead
to disproportionately large increases in plasma levels, significantly increasing the risk of
toxicity. Option A describes first-order kinetics, which applies to most drugs at therapeutic
doses but not theophylline at higher concentrations. Option C incorrectly mixes kinetics
types. Option D is incorrect because theophylline is primarily metabolized by CYP1A2 in the
liver, not eliminated renally.
Q7: A nurse is caring for a patient with a creatinine clearance (CrCl) of 15
mL/min who is prescribed gentamicin. Which of the following adjustments is
most appropriate based on this patient's renal function?
A. No adjustment needed because gentamicin is not renally eliminated
B. Increase the dose to compensate for decreased renal clearance
C. Extend the dosing interval because the drug is primarily eliminated by the
kidneys and clearance is significantly reduced [CORRECT]
D. Decrease the dose and shorten the dosing interval to maintain steady levels
Correct Answer: C
Rationale:
Gentamicin is an aminoglycoside antibiotic that is eliminated almost entirely by glomerular
filtration. In a patient with a CrCl of 15 mL/min (severe renal impairment), the dosing
interval should be extended (e.g., every 24-48 hours) while maintaining the usual dose per
administration to prevent drug accumulation and ototoxicity or nephrotoxicity. Option A is
incorrect because gentamicin is primarily renally cleared. Option B would increase toxicity
risk. Option D is incorrect because shortening the interval would lead to drug accumulation
in renal impairment.
HESI RN ADVANCED PHARMACOLOGY EXAM 2026/2027
PHARMACOLOGY EXAM
NEWEST VERSION | 2026/2027
Actual Exam Complete | Already Graded A+
160 Questions | 13 Content Sections
Aligned with NCBSN Pharmacology Competencies
Format Multiple Choice (A-D) | Verified Answers
Total Questions 160
Sections 13 (Pharmacokinetics through Case Studies)
Cognitive Levels 25% Recall | 55% Application | 20% Analysis
Focus Drug Therapy Integration & Clinical Application
160 Questions | 13 Sections | Verified Answers with Detailed Rationales
,HESI RN Advanced Pharmacology Exam 2026/2027 Page 2
Section 1: Pharmacokinetics and Pharmacodynamics
Q1: A nurse is administering a medication that undergoes extensive
first-pass metabolism. Which of the following best describes the effect of
first-pass metabolism on the drug?
A. Increased bioavailability of the active drug
B. Decreased bioavailability due to hepatic inactivation before reaching
systemic circulation [CORRECT]
C. Enhanced renal excretion of the drug
D. Prolonged half-life of the drug
Correct Answer: B
Rationale:
First-pass metabolism refers to the hepatic inactivation of a drug before it reaches systemic
circulation, significantly reducing its bioavailability. Drugs undergoing extensive first-pass
effect (e.g., morphine, propranolol, nitroglycerin) often require alternative routes such as
sublingual or IV administration to bypass this effect. Options A and D are incorrect because
first-pass metabolism reduces, not increases, bioavailability and does not directly
determine half-life. Option C is incorrect because first-pass metabolism involves hepatic
metabolism, not renal excretion.
Q2: A patient with severe liver cirrhosis is prescribed a highly protein-bound
drug (99% bound to albumin). The nurse should understand that which of
the following is the most likely consequence in this patient?
A. Decreased free drug concentration due to increased albumin synthesis
B. Increased free drug concentration leading to an enhanced
pharmacological effect and risk of toxicity [CORRECT]
C. No change in drug effect because protein binding is unaffected by liver disease
D. Increased rate of renal excretion due to decreased protein binding
Correct Answer: B
Rationale:
Severe liver cirrhosis impairs albumin synthesis, leading to hypoalbuminemia and fewer
available protein-binding sites. This increases the fraction of unbound (free) drug, which is
the pharmacologically active form, thereby enhancing drug effect and increasing the risk of
toxicity. Option A is incorrect because the liver synthesizes albumin and cirrhosis
decreases, not increases, albumin production. Option C is incorrect because protein
binding is directly affected by decreased albumin levels. Option D describes a potential
downstream effect but is not the most direct or immediate consequence of
hypoalbuminemia.
Q3: A nurse is reviewing medications for a patient with a severe systemic
infection. Which characteristic of a drug's volume of distribution (Vd) best
explains why certain antibiotics (e.g., vancomycin) have limited penetration
into cerebrospinal fluid?
HESI RN ADVANCED PHARMACOLOGY EXAM 2026/2027
,HESI RN Advanced Pharmacology Exam 2026/2027 Page 3
A. Low Vd indicates the drug is confined to the bloodstream and interstitial
fluid [CORRECT]
B. High Vd indicates the drug readily crosses the blood-brain barrier
C. Low Vd increases the drug's half-life in cerebrospinal fluid
D. High Vd decreases the drug's protein-binding capacity
Correct Answer: A
Rationale:
A low volume of distribution means the drug is primarily confined to the intravascular
space and interstitial fluid, with limited distribution into tissues including the central
nervous system. Vancomycin has a relatively low Vd and does not readily cross the
blood-brain barrier, which is why it has limited CSF penetration unless the meninges are
inflamed. Option B is incorrect because a high Vd indicates wide tissue distribution but
does not guarantee BBB penetration. Options C and D are incorrect because Vd does not
directly determine half-life in CSF or protein-binding capacity.
Q4: A nurse is caring for a client who is taking warfarin (Coumadin) and is
prescribed phenobarbital for seizures. Which of the following explains the
likely interaction between these two medications?
A. Phenobarbital inhibits CYP2C9, increasing warfarin levels and bleeding risk
B. Phenobarbital induces CYP450 enzymes, decreasing warfarin's
anticoagulant effect [CORRECT]
C. Phenobarbital competes with warfarin for plasma protein-binding sites,
increasing free warfarin
D. Phenobarbital decreases warfarin absorption by increasing gastric pH
Correct Answer: B
Rationale:
Phenobarbital is a potent CYP450 enzyme inducer that increases the hepatic metabolism of
warfarin, a CYP2C9 substrate, leading to decreased warfarin levels and a reduced
anticoagulant effect. This is a pharmacokinetic interaction involving enzyme induction, and
patients may require higher warfarin doses or closer INR monitoring. Option A is incorrect
because phenobarbital induces, not inhibits, CYP enzymes. Option C is incorrect because
the primary interaction mechanism is enzyme induction, not protein-binding displacement.
Option D is incorrect because phenobarbital does not significantly alter gastric pH or
warfarin absorption.
Q5: A patient receives an IV bolus of a medication with a half-life of 4 hours.
Approximately how many hours will it take for the drug to reach
approximately 94% of steady-state concentration with a continuous infusion?
A. 8 hours
B. 12 hours
C. 16 hours [CORRECT]
D. 24 hours
Correct Answer: C
Rationale:
HESI RN ADVANCED PHARMACOLOGY EXAM 2026/2027
, HESI RN Advanced Pharmacology Exam 2026/2027 Page 4
It takes approximately 4 to 5 half-lives for a drug to reach steady-state concentration during
continuous infusion. At 4 half-lives (4 × 4 = 16 hours), approximately 94% of steady-state is
achieved. At 5 half-lives (20 hours), approximately 97% is achieved. Eight hours (2
half-lives) reaches only about 75%, and 12 hours (3 half-lives) reaches about 87.5%, making
16 hours the best answer for "approximately 94%." Option D (24 hours) exceeds the time
needed for 94% steady-state.
Q6: A nurse is administering theophylline intravenously to a patient with an
acute asthma exacerbation. The nurse should recognize that theophylline
follows which type of kinetics and what is the clinical implication?
A. First-order kinetics; a constant fraction of the drug is eliminated per unit time
B. Zero-order kinetics; a constant amount of the drug is eliminated per unit
time and small dose increases can cause disproportionate toxicity
[CORRECT]
C. First-order kinetics; a constant amount of the drug is eliminated per unit time
D. Zero-order kinetics; the drug is primarily eliminated by renal excretion
Correct Answer: B
Rationale:
Theophylline follows zero-order (saturable) kinetics at therapeutic or near-toxic
concentrations, meaning a constant amount of drug is eliminated per unit time rather than
a constant fraction. In zero-order kinetics, small increases in dose or concentration can lead
to disproportionately large increases in plasma levels, significantly increasing the risk of
toxicity. Option A describes first-order kinetics, which applies to most drugs at therapeutic
doses but not theophylline at higher concentrations. Option C incorrectly mixes kinetics
types. Option D is incorrect because theophylline is primarily metabolized by CYP1A2 in the
liver, not eliminated renally.
Q7: A nurse is caring for a patient with a creatinine clearance (CrCl) of 15
mL/min who is prescribed gentamicin. Which of the following adjustments is
most appropriate based on this patient's renal function?
A. No adjustment needed because gentamicin is not renally eliminated
B. Increase the dose to compensate for decreased renal clearance
C. Extend the dosing interval because the drug is primarily eliminated by the
kidneys and clearance is significantly reduced [CORRECT]
D. Decrease the dose and shorten the dosing interval to maintain steady levels
Correct Answer: C
Rationale:
Gentamicin is an aminoglycoside antibiotic that is eliminated almost entirely by glomerular
filtration. In a patient with a CrCl of 15 mL/min (severe renal impairment), the dosing
interval should be extended (e.g., every 24-48 hours) while maintaining the usual dose per
administration to prevent drug accumulation and ototoxicity or nephrotoxicity. Option A is
incorrect because gentamicin is primarily renally cleared. Option B would increase toxicity
risk. Option D is incorrect because shortening the interval would lead to drug accumulation
in renal impairment.
HESI RN ADVANCED PHARMACOLOGY EXAM 2026/2027
